| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.13 | 0.02 |